Name | Type | Posted | Actions |
|---|---|---|---|
Amendment_5to_the_RFP_-_10-18-2024_0005.pdf | Oct 18, 2024 | ||
Amendment_4_to_the_RFP_-_10-11-2024_0004.pdf | Oct 11, 2024 | ||
Amendment_3_to_the_RFP_-_10-08-2024_0003.pdf | Oct 8, 2024 | ||
Amendment_2_to_the_RFP_-_9-20-24_0002.pdf | Sep 20, 2024 | ||
Amendment_1_to_RFP_75N94024R00008_9-11-24_0001.pdf | Sep 11, 2024 | ||
Sol_75N94024R00008.pdf | Sep 4, 2024 |
A--BPCA Pediatric Trials Network
A--BPCA Pediatric Trials Network
Contact and place of performance
OSINSKI, ELIZABETH J
Not specified
Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN)
The National Institutes of Health, specifically the National Institute of Child Health and Human Development (NICHD), is soliciting proposals for the Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN). This requirement is classified under PSC AN11 for Health R&D Services, Health Care Services, and Basic Research, as well as NAICS 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Solicitation 75N94024R00008 has a response deadline of November 4, 2024. The administrative record for this notice includes six attachments, consisting of the original solicitation and five amendments published between September 11, 2024, and October 18, 2024. Elizabeth J. Osinski is the designated point of contact for this procurement.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.